Chiome
4583.TChiome Bioscience Inc. Price (4583.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
58,207,957
(17.4846)%Revenue and Profitability
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Revenue | 447,576,000 | 480,853,000 | 712,932,000 | 630,815,000 | 682,464,000 | 780,809,000 |
| Net Income | -1,403,821,000 | -1,293,798,000 | -1,479,895,000 | -1,242,871,000 | -1,220,018,000 | -1,020,776,000 |
| FCF USD | -1,537,360,000 | -1,360,143,000 | -1,131,291,000 | -1,191,009,000 | -1,069,192,000 | -1,000,664,000 |
| OCF USD | -1,537,360,000 | -1,360,143,000 | -1,131,291,000 | -1,191,009,000 | -1,069,192,000 | -1,000,664,000 |
Financial Health - DEBT
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| D/E | 0.00 | 0.06 | 0.10 | 0.10 | 0.25 | 0.15 |
| CA/CL | 17.65 | 9.48 | 5.65 | 5.65 | 3.02 | 4.74 |
| TA/TL | 19.35 | 9.09 | 5.24 | 5.22 | 2.95 | 4.50 |
| Total Debt | 0 | 180,000,000 | 183,000,000 | 184,000,000 | 291,000,000 | 281,500,000 |
Management Performance
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| ROIC | -52.74% | -38.62% | -63.22% | -62.28% | -80.49% | -45.82% |
| ROE | -53.55% | -41.60% | -78.18% | -69.41% | -105.38% | -53.16% |
| ROA | 0.00% | -36.93% | -62.68% | -55.87% | -69.37% | -41.35% |
| NM % | -313.65% | -269.06% | -207.58% | -197.03% | -178.77% | -130.73% |
| FCF / R% | 0.00% | -282.86% | -158.68% | -188.80% | -156.67% | -128.16% |
| FCF / NI% | 109.51% | 105.39% | 77.15% | 96.22% | 88.00% | 98.03% |
| Operating Margin (OM) | 0.00 | -2.69 | -3.89 | -6.37 | -7.67 | 1.17 |
Per Share
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| EPS | -44.61 | -36.06 | -36.74 | -28.26 | -24.62 | -17.54 |
| SPS | 14.22 | 13.40 | 17.70 | 14.34 | 13.77 | 13.41 |
| OCPS | -48.85 | -37.91 | -28.09 | -27.08 | -21.58 | -17.19 |
| FCPS | -48.85 | -37.91 | -28.09 | -27.08 | -21.58 | -17.19 |
| BVPS | 84.62 | 86.68 | 47.00 | 40.71 | 23.37 | 32.99 |
Per Share - CAGR
| Year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| CAGR-EPS | -44.61 | -36.06 | -36.74 | -28.26 | -24.62 | -17.54 |
| CAGR-SPS | 14.22 | 13.40 | 17.70 | 14.34 | 13.77 | 13.41 |
| CAGR-OCPS | -48.85 | -37.91 | -28.09 | -27.08 | -21.58 | -17.19 |
| CAGR-FCPS | -48.85 | -37.91 | -28.09 | -27.08 | -21.58 | -17.19 |
| CAGR-BVPS | 84.62 | 86.68 | 47.00 | 40.71 | 23.37 | 32.99 |